Valve-like tissues may mimic inflammatory disease
-
By
-
Andrea Surnit
-
August 19, 2026
-
4 min
By
Andrea Surnit
August 19, 2026
Phase 3 VERIFY results showed a 77% clinical response rate during weeks 20 to 32.
August 31, 2026
Randomized trial found significant weight loss did not improve atrial fibrillation severity or burden in older patients with persistent disease.
June 15, 2026
Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.
June 16, 2026